Efficacy of the Cardiac Rehabilitation Program in Patients with End-Stage Heart Failure, Heart Transplant Patients, and Left Ventricular Assist Device Recipients

被引:61
|
作者
Karapolat, H. [1 ]
Engin, C. [2 ]
Eroglu, M. [1 ]
Yagdi, T. [2 ]
Zoghi, M. [2 ]
Nalbantgil, S. [2 ]
Durmaz, B. [1 ]
Kirazli, Y. [1 ]
Ozbaran, M. [2 ]
机构
[1] Ege Univ, Phys Med & Rehabil Dept, TR-35100 Izmir, Turkey
[2] Ege Univ, Dept Cardiac Surg, TR-35100 Izmir, Turkey
关键词
QUALITY-OF-LIFE; FUNCTIONAL-CAPACITY; DEPRESSIVE SYMPTOMS; EXERCISE CAPACITY; TIME-COURSE; METAANALYSIS; TRIAL;
D O I
10.1016/j.transproceed.2013.06.009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective. The objective of this study was to assess the effects of cardiac rehabilitation on the functional capacity, pulmonary functions, quality of life, and psychological state of patients who had heart failure (HF), heart transplantation (HTx), or a left ventricular assist device (LVAD). Methods. An 8-week exercise program was undertaken by 46 patients diagnosed with end-stage heart failure, 40 of whom had a heart transplantation and 11 were implanted with an LVAD. The patients' functionality was assessed with a maximal oxygen consumption test (pVO(2)), their psychological state with the Beck Depression Inventory (BDI) and State-Trait Anxiety Inventory (STAI), their quality of life (QOL) with the Short Form 36 (SF 36), and their pulmonary condition with pulmonary function tests (PFTs). Results. A significant improvement was observed in all forced vital capacity (%), forced expiratory volume in 1 second (%), pVO(2), BDI, and most of the subscores of the SF 36 scores at the end of the exercise, compared with the pre-exercise period (P <.05). The intergroup evaluations showed no significant differences among the 3 groups in terms of all assessed changes (F>.05). Conclusion. An 8-week supervised exercise program was observed to improve functional capacity, PFT, QOL, and depression among patients who had HF, HTx, or LVAD. Supervised exercise should be recommended for every patient included in a heart transplant program.
引用
收藏
页码:3381 / 3385
页数:5
相关论文
共 50 条
  • [11] Cancer in End-Stage Heart Failure Patients Supported by Left Ventricular Assist Devices
    Loyaga-Rendon, Renzo Y.
    Inampudi, Chakradhari
    Tallaj, Jose A.
    Acharya, Deepak
    Pamboukian, Salpy V.
    ASAIO JOURNAL, 2014, 60 (05) : 609 - 612
  • [12] Stability of Cardiac Function after Left Ventricular Assist Device Weaning in End-Stage Heart Failure
    Taleb, I.
    Yin, M.
    Koliopoulou, A.
    Kyriakopoulos, C. P.
    Nativi-Nicolau, J.
    Wever-Pinzon, O.
    McKellar, S. H.
    Dranow, E.
    Stehlik, J.
    Gilbert, E. M.
    Fang, J. C.
    Selzman, C. H.
    Drakos, S. G.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (04): : S349 - S349
  • [13] Calciotropic and Phosphaturic Hormones in End-Stage Heart Failure Patients Supported by a Left-Ventricular Assist Device
    Zittermann, Armin
    Ernst, Jana B.
    Pilz, Stefan
    Dreier, Jens
    Kuhn, Joachim
    Knabbe, Cornelius
    Gummert, Jan F.
    Morshuis, Michiel
    Milting, Hendrik
    PLoS One, 2016, 11 (10):
  • [14] Perioperative Levosimendan Infusion in Patients With End-Stage Heart Failure Undergoing Left Ventricular Assist Device Implantation
    Abdelshafy, Mahmoud
    Elsherbini, Hagar
    Elkoumy, Ahmed
    Simpkin, Andrew J.
    Elzomor, Hesham
    Caliskan, Kadir
    Soliman, Osama
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [15] Cardiac Rehabilitation for Severe Heart Failure Patients with Ventricular Assist Device
    Makita, Shigeru
    JOURNAL OF CARDIAC FAILURE, 2012, 18 (10) : S143 - S143
  • [16] Implanting left ventricular assist device in end-stage heart failure with massive ventricular aneurysm
    Yao, Shaowen
    Qin, Yannv
    Yue, Jiarui
    Lu, Shichun
    ASIAN JOURNAL OF SURGERY, 2024, 47 (07) : 3332 - 3334
  • [17] Hypomagnesemia after heart transplantation or left ventricular assist device implant for end-stage heart failure
    Racca, Vittorio
    Scaglione, Anna
    De Maria, Renata
    Panzarino, Claudia
    Santangelo, Maria Antonia
    Cipriani, Manlio
    CLINICAL TRANSPLANTATION, 2020, 34 (08)
  • [18] Cardiac molecular markers of programmed cell death are activated in end-stage heart failure patients supported by left ventricular assist device
    Prescimone, Tommaso
    Masotti, Silvia
    D'Amico, Andrea
    Caruso, Raffaele
    Cabiati, Manuela
    Caselli, Chiara
    Viglione, Federica
    Verde, Alessandro
    Del Ry, Silvia
    Giannessi, Daniela
    CARDIOVASCULAR PATHOLOGY, 2014, 23 (05) : 272 - 282
  • [19] Ventricular Assist Device Support in End-Stage Heart Failure From Cardiac Amyloidosis
    Lim, Choon Pin
    Lim, Yeong Phang
    Lim, Chong Hee
    Ong, Hean Yee
    Tan, Daryl
    Chew, Huck Chin
    Omar, Abdul Razakjr
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2019, 48 (12) : 435 - 438
  • [20] An Old Ventricular Assist Device Still Working for Patients With End-Stage Heart Failure in Japan
    Morita, Shigeki
    CIRCULATION JOURNAL, 2011, 75 (01) : 53 - 54